Clinical Trial Update: NeoVas Bioresorbable Coronary Scaffold Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial evaluating the NeoVas bioresorbable coronary scaffold for coronary artery disease; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• NeoVas Bioresorbable Coronary Scaffold

Snippet

Sponsor: Lepu Medical Technology (Beijing) Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN